CAJ | 학술논문

目的：探讨脑心通胶囊联合阿托伐他汀治疗脑梗死颈动脉粥样硬化的临床疗效。方法选择于2013年1月～2014年12月来我院接受诊治的86例颈动脉粥样硬化脑梗死患者为研究对象，采用随机数字表法将其分为两组，对照组接受阿托伐他汀联合阿司匹林药物治疗，观察组患者接受对照组治疗的基础上，联合服用脑心通胶囊。结果观察组治疗后的TG、TC、LDL-C、HDL-C含量水平为（0.65±0.13） mmol/L、（2.68±0.26）mmol/L、（1.86±0.37）mmol/L、（1.82±0.23） mmol/L，优于对照组，P＜0.05，差异具有统计学意义。结论阿托伐他汀联合脑心通胶囊治疗脑梗死颈动脉粥样硬化疾病，具有较高的安全性及有效性。
목적：탐토뇌심통효낭연합아탁벌타정치료뇌경사경동맥죽양경화적림상료효。방법선택우2013년1월～2014년12월래아원접수진치적86례경동맥죽양경화뇌경사환자위연구대상，채용수궤수자표법장기분위량조，대조조접수아탁벌타정연합아사필림약물치료，관찰조환자접수대조조치료적기출상，연합복용뇌심통효낭。결과관찰조치료후적TG、TC、LDL-C、HDL-C함량수평위（0.65±0.13） mmol/L、（2.68±0.26）mmol/L、（1.86±0.37）mmol/L、（1.82±0.23） mmol/L，우우대조조，P＜0.05，차이구유통계학의의。결론아탁벌타정연합뇌심통효낭치료뇌경사경동맥죽양경화질병，구유교고적안전성급유효성。
Objective Observation curative effect of naoxintong capsule combine with atorvastatin in treatment of carotid atherosclerotic cerebral infarction.MethodsSelected 86 cases of patients with carotid atherosclerotic cerebral infarction from January 2013 to December 2014 in our hospital as the research object, were divided into two groups by randomly number table method, the control group patients received atorvastatin combined aspirin therapy, the observation group on the basis of the control group treated, took heart failure capsule joint. Results The observation group after treatment of TG, TC, LDL, HDL-C levels was (0.65±0.13) mmol/L, (2.68±0.26 ) mmol/L, (1.86±0.37) mmol/L, (1.82±0.23) mmol/L was better than control group,P<0.05, had difference statistically signiifcance. Conclusion Atorvastatin combined heart failure capsule treatment of cerebral infarction carotid atherosclerotic disease, has the high safety and efifcacy.